Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Veramarx, Inc. logo — company profile

Veramarx, Inc.

Founded 2012 1 employees Seed Total: $500.00K Health Care

General Information

Company Name Veramarx, Inc.
Founded Year 2012
Employees 1
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Veramarx, Inc.. To contact Veramarx, Inc., visit veramarx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Veramarx, Inc. compare?

A PDF of Veramarx, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Veramarx, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Veramarx, Inc.

Veramarx, Inc. focuses on providing accurate diagnostic tests for early-stage Lyme disease, which is a rapidly growing infectious disease in the US and Western Europe. According to their description, the current diagnostic tests for Lyme disease are highly inaccurate, missing over 60% of cases in the early stage. The company was founded in 2012 and received a Seed Round investment from gener8tor on 01 May 2017. With the potential to revolutionize the early diagnosis and treatment of Lyme disease, Veramarx, Inc. presents an exciting opportunity for venture capital investments. The growing demand for accurate diagnostic tools in the healthcare industry, coupled with the urgency of addressing infectious diseases, positions Veramarx as a promising investment prospect.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
gener8tor
gener8tor
01 May 2017
Angel Round $500.00K -
01 Mar 2017
Seed Round Undisclosed 1
SoundBoard Venture Fund
SoundBoard Venture Fund
01 Jan 2015

Veramarx, Inc. Alternatives & Competitors

View All Alternatives
Veramarx, Inc. vs
Selah Genomics Inc
Selah Genomics Inc United States

Selah Genomics is a personalized medicine diagnostic specialist supporting healthcare providers and...

Debt Financing
1 employees
Biotechnology, Health Care
Veramarx, Inc. vs
PrognostX Health
PrognostX Health

PrognostX Health is a company dedicated to the discovery and clinical optimization of novel diagnost...

Grant
4 employees
Health Care
Veramarx, Inc. vs
Biocartis
Biocartis Belgium

High precision diagnostics for personalized medicine

Grant
314 employees
Biotechnology, Health Care
View all alternatives

FAQ About Veramarx, Inc.

Veramarx offers the only accurate diagnostic test for early-stage Lyme disease, which is one of the fastest growing infectious disease in the US and Western Europe. Lyme disease can only be treated effectively when diagnosed at the early stage of infection, when 75% of patients visit the doctor. Cur...
Veramarx, Inc. was founded in 2012.
Veramarx, Inc. operates in Health Care.
Veramarx, Inc. has approximately 1 employees.
Veramarx, Inc. has completed 3 funding rounds, raising a total of $500.00K. The latest funding stage is Seed.
Top alternatives and competitors to Veramarx, Inc. include Selah Genomics Inc, PrognostX Health, Biocartis, IMMY, Redcliffe Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Veramarx, Inc. and Selah Genomics Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Veramarx, Inc., https://bouncewatch.com/company/veramarx-inc, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes